BEIJING,Nov. 20,2024-- On November 18 and 19,the 19th Heads of State and Government Summit of the Group of 20 (G20) took place in Rio de Janeiro,Brazil. Chinese PresidentXi Jinping on November 18 deli
BAKU,Azerbaijan,Nov. 20,2024-- On November 16,2024,the official side event "Belt and Road" Climate Mitigation and Adaptation: Cases and Practices,hosted by the All-China Environment Federati
NEW YORK,Sept. 20,2024-- US-based EvolutionIQ,a global leader in claims guidance technology,has signed on as the Council of Australian Life Insurers (CALI)\'s first Life Partner as part of its corpo
LIMASSOL,Cyprus,Sept. 20,2024--Ultima Markets,a leading global forex and CFDs brokerage,is thrilled to announce its double success at the prestigious Global Forex Awards – Retail 2024. The company w
For the first time,supply chain leaders gain access to a platform equal or superior to their executive counterparts in Sales,Marketing,HR,and Finance
Driving the Future of Smart Field Deployment in a Joint Demonstration with Anritsu TAIPEI,Sept. 20,2024-- TMY Technology Inc. (TMYTEK),a pioneering provider of millimeter-wave (mmWave) solutions,will
Phygital exhibition of 3D,digitally generated art and garment designs drew 422 attendees,highlighting how 3D-powered virtual experiences are merging the gaming and fashion worlds.
YOKOHAMA,Japan,Sept. 18,2024-- - New System Integrates AI Technology and Home Healthcare Launched in July 2024 -
VANCOUVER,BC,Sept. 18,2024-- September 18,2024 – Sydney,Australia Patriot Battery Metals Inc. (the "Company" or "Patriot") (TSX: PMET) (ASX: PMT) (OTCQX: PMETF) (FSE: R9GA)is ple
HONG KONG,Sept. 18,2024-- CNOOC Limited (the "Company",SEHK: 00883 (HKD Counter) and 80883 (RMB Counter),SSE: 600938) announces today that thanks to its mature typhoon response measures,the
LOS ANGELES,Sept. 18,2024-- PrintKK,a leading provider of print-on-demand solutions for e-commerce,recently announced an expanded integration with Shopify. This allows Shopify merchants to effortlessl
Updated results with longer follow-up reveal confirmed ORR of 68% and median PFS of 14.2 months in patients with CLDN18.2 high or medium expression,known PD-L1 CPS (n=66).
© OfficialAffairs
